EMA Recommends New Hematology and Supportive Care Drugs Edited by Zeel Mehta

https://www.medscape.com/viewarticle/ema-recommends-new-hematology-and-neutropenia-drugs-2026a1000peb?src= Two established hematology-oncology treatments, a generic ruxolitinib and a pegfilgrastim biosimilar, moved closer to EU approval after the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued positive opinions for both at its July meeting.